Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy.
Naveen PemmarajuHagop M KantarjianLoretta J NastoupilMegan DupuisLisa ZhouSherry PierceKeyur P PatelLucia MasarovaJorge E CortesSrdan VerstovsekPublished in: Blood (2019)